EPISODE · Jun 1, 2019 · 28 MIN
Anti-Biotic Resistance
from The Bottom Line · host BBC Radio 4
Antibiotic resistance is a global problem but there have been no new drugs produced since the 1980s. So who is to blame? The public's over-consumption or the current economic model for drug research and production? Evan Davis and guests discuss.GUESTSSeema Patel, Medical Director, Hospital Business, Pfizer, UK, Ireland and the NordicsLord Jim O'Neill, Chair Anti-Microbial Resistance Review (2016), Former Chief Economist, Goldman SachsProfessor Colin Garner, Co Founder and Director, Antibiotic Research UK
Embed this episode
NOW PLAYING
Anti-Biotic Resistance
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.